Latest News in the pharma Industry
Research & Development
MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities
17 Jul 2016
The charity will now also be able to pursue exciting novel research and development collaborations with new partners.
Read more
Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer
17 Jul 2016
Study to evaluate potential of novel combination therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative (HR+, HER2-) metastatic breast cancer (mBC).
Read more
Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class
14 Jul 2016
The collaboration will evaluate the use of Avacta’s Affimer technology in combination with Glythera’s PermaLink conjugation chemistry.
Read more
EC grants marketing authorization for Gilead’s Epclusa for the treatment of all genotypes of chronic hepatitis C
10 Jul 2016
Epclusa is the first and only all-oral, single tablet regimen for all genotypes (1-6) of chronic hepatitis C virus infection and is Gilead’s third Sofosbuvir-based treatment.
Read more
FDA approves Genentech’s Xolair for allergic asthma in children
8 Jul 2016
Approval makes Xolair the only biologic for children ages six and up with uncontrolled allergic asthma.
Read more
EC approves extended indication for Amgen's Kyprolis
4 Jul 2016
Head-to-head Phase III trial demonstrated superiority of Kyprolis and dexamethasone over Velcade and dexamethasone in patients with relapsed multiple myeloma.
Read more
Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda
4 Jul 2016
Collaboration combines Merck’s leadership in immuno-oncology with Moderna’s pioneering mRNA vaccine technology and rapid cycle time, small-batch GMP manufacturing capabilities.
Read moreLEO Pharma enters biologics through strategic partnership with AstraZeneca
1 Jul 2016
The partnership covers potential new medicines for atopic dermatitis and psoriasis.
Read more
BMS and PsiOxus Therapeutics announce immuno-oncology clinical collaboration
30 Jun 2016
Companies will evaluate the combination of Opdivo and enadenotucirev to treat a range of tumour types in late-stage cancer patients.
Read more
BoneAlbumin induces better bone formation
29 Jun 2016
Positive results in a double-blind controlled study in the knee.
Read more
GSK's MenABCWY vaccine set to revolutionize meningococcal disease prevention market
29 Jun 2016
Should the MenABCWY vaccine perform well in upcoming Phase III studies, it has the potential to become market leader, says GlobalData.
Read more
FDA Advisory Committee recommends approval of Jardiance for cardiovascular indication
29 Jun 2016
Endocrinologic and Metabolic Drugs Advisory Committee votes in favour of cardiovascular mortality benefit for JARDIANCE for adults with type 2 diabetes.
Read more